Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

[Clinical research in private sector: Which strategic analysis?]

Author information

Affiliations

  • 1. Centre Jean-Bernard, institut inter-régional de cancérologie (ILC), CCS, 64, rue de Degré, 72000 Le Mans, France; Sorecoh, centre Jean-Bernard, 64, rue de Degré, 72000 Le Mans, France; WeProm, centre Jean-Bernard, 64, rue de Degré, 72000 Le Mans, France.
      Authors
    • Ruffier A 1
    • Pointreau Y 1
    (2 authors)
  • 2. Centre Jean-Bernard, institut inter-régional de cancérologie (ILC), CCS, 64, rue de Degré, 72000 Le Mans, France; Sorecoh, centre Jean-Bernard, 64, rue de Degré, 72000 Le Mans, France.
      Authors
    • Sacier V 2
    (1 author)
  • 3. Centre Jean-Bernard, institut inter-régional de cancérologie (ILC), CCS, 64, rue de Degré, 72000 Le Mans, France; WeProm, centre Jean-Bernard, 64, rue de Degré, 72000 Le Mans, France.
      Authors
    • Balavoine M 3
    (1 author)
  • 4. Département R&D, Unicancer, 75013 Paris, France.
      Authors
    • Lamrani-Ghaouti A 4
    (1 author)
  • 5. Institut de cancérologie de Strasbourg (ICANS), 17, rue Albert-Calmette, BP 2305, 67033 Strasbourg, France.
      Authors
    • Guihard S 5
    (1 author)
    • Show all (6)

Cancer Radiotherapie : Journal de la Societe Francaise de Radiotherapie Oncologique, 16 Aug 2023, 27(6-7):469-473Language:fre
https://doi.org/10.1016/j.canrad.2023.06.023 PMID: 37596122 

Abstract 

Clinical research in private practice has significantly increased in recent years and has become crucial for the attractiveness of centres both for patients who can access innovative treatments and molecules and for participating physicians. The responsiveness, the size and reduced number of interlocutors, flexibility, and decision-making autonomy of private practitioners are strengths in the strategic analysis of clinical research in the private sector. However, the varied medical activity allowing for broader recruitment, location of practice, and administrative time related leadership roles can become weakness in terms of quality and time dedicated to this research activity, which still relies heavily on strong individual involvement. Collaborations, which develop when clinical research in private centres is dynamic, are sources of opportunities, growth, and progress, allowing participation in various ambitious projects that can benefit patients in these facilities. Recent administrative and legislative complexities for trial integration and competition with academic structures can threaten this important clinical research activity for private practices, requiring reflection on its valorisation and promotion to ensure its sustainability.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/j.canrad.2023.06.023

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.